Icon PLC Enjoying Wall Street Bonanza And FDA Tailwind

|
About: ICON Public Limited Company (ICLR), Includes: CRL, IQV, LH, MEDP, PFE, PRAH, SYNH
by: Sergio Heiber
This article is exclusive for subscribers.
Sergio Heiber
Long-term horizon, micro-cap, nano-cap
Summary

ICON is one of the market share leaders in a fast growing market industry that has penetrated only about half of its target market.

The industry position and free cash flow makes ICON an attractive takeover candidate in an industry that is experiencing heavy M&A activity.

The industry is receiving favorable FDA tailwinds.

Icon PLC (ICLR) is an Irish based Contract Research Organization. CROs conduct clinical research, gather patients and doctors and leads their drug developing clients through the regulatory approval process. The company has a